Literature DB >> 31724683

Dual-responsive nanogels based on oligo(ethylene glycol) methacrylates and acidic co-monomers.

Micaela A Macchione1, M Florencia Sacarelli, Ana C Racca, Catalina Biglione, Graciela M Panzetta-Dutari, Miriam C Strumia.   

Abstract

Ethylene glycol-based nanogels (NGs) have demonstrated their potential for the development of next-generation formulations for biomedical applications due to their interesting properties. In this work, monodispersed NGs based on oligo(ethylene glycol) methacrylates (OEG) were synthesized through free radical precipitation/dispersion polymerization assisted by ultrasonication. Di(ethylene glycol)methyl ether methacrylate (DEGMA) and oligo(ethylene glycol) methacrylate (OEGMA; Mn 475 g mol-1) were used as the main monomers, acrylic acid (AA) or itaconic acid (IA) as co-monomers (OEG-co-AA and OEG-co-IA, respectively) and tetraethylene glycol dimethacrylate (TEGDMA) as crosslinker. The physicochemical properties of OEG-co-AA and OEG-co-IA NGs were studied including hydrodynamic diameter, poly-dispersity index, zeta potential and pH/temperature responsiveness. Samples with 4 mol% of both AA and IA showed nanometric sizes. Regarding their thermo-responsiveness, unexpected differences between NGs with AA or with IA were observed. Besides, NGs did not impair the cell viability of a breast tumour cell line even when high concentrations were added to the culture medium. The properties of the synthetized NGs showed that either NGs with 4% AA or with 4% IA are outstanding candidates for biomedical applications.

Entities:  

Year:  2019        PMID: 31724683     DOI: 10.1039/c9sm01180c

Source DB:  PubMed          Journal:  Soft Matter        ISSN: 1744-683X            Impact factor:   3.679


  1 in total

Review 1.  Nanosystems Applied to HIV Infection: Prevention and Treatments.

Authors:  Micaela A Macchione; Dariana Aristizabal Bedoya; Francisco N Figueroa; María Ángeles Muñoz-Fernández; Miriam C Strumia
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.